Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 11 | 2024 | 323 | 2.850 |
Why?
|
| Leukocytes | 5 | 2025 | 209 | 1.760 |
Why?
|
| P-Selectin | 4 | 2020 | 68 | 1.660 |
Why?
|
| Vimentin | 4 | 2024 | 69 | 1.470 |
Why?
|
| Leukapheresis | 3 | 2025 | 14 | 1.330 |
Why?
|
| Microfluidics | 3 | 2025 | 28 | 1.000 |
Why?
|
| Membrane Glycoproteins | 3 | 2020 | 421 | 0.980 |
Why?
|
| Intravital Microscopy | 2 | 2022 | 19 | 0.920 |
Why?
|
| Neutrophils | 3 | 2021 | 360 | 0.910 |
Why?
|
| Thrombosis | 6 | 2022 | 528 | 0.860 |
Why?
|
| Cannula | 1 | 2024 | 31 | 0.850 |
Why?
|
| Histones | 3 | 2022 | 535 | 0.830 |
Why?
|
| Cell Adhesion | 2 | 2020 | 320 | 0.760 |
Why?
|
| Respiratory Insufficiency | 2 | 2024 | 247 | 0.740 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2025 | 659 | 0.730 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 486 | 0.730 |
Why?
|
| Endotoxemia | 2 | 2020 | 55 | 0.720 |
Why?
|
| Liver Transplantation | 7 | 2024 | 1102 | 0.660 |
Why?
|
| Pneumonia | 1 | 2024 | 333 | 0.660 |
Why?
|
| von Willebrand Diseases | 2 | 2022 | 54 | 0.650 |
Why?
|
| Echocardiography | 2 | 2024 | 1126 | 0.600 |
Why?
|
| Platelet Aggregation | 2 | 2024 | 106 | 0.600 |
Why?
|
| Acetaminophen | 2 | 2021 | 97 | 0.600 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 1350 | 0.600 |
Why?
|
| Epithelium, Corneal | 3 | 2021 | 171 | 0.520 |
Why?
|
| Corneal Injuries | 2 | 2021 | 35 | 0.490 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2015 | 2 | 0.480 |
Why?
|
| Antithrombin III | 1 | 2015 | 26 | 0.480 |
Why?
|
| Corneal Keratocytes | 1 | 2015 | 5 | 0.470 |
Why?
|
| End Stage Liver Disease | 4 | 2024 | 191 | 0.450 |
Why?
|
| Cell Separation | 5 | 2025 | 226 | 0.450 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 143 | 0.440 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 123 | 0.430 |
Why?
|
| Hepatocytes | 1 | 2015 | 239 | 0.420 |
Why?
|
| von Willebrand Factor | 5 | 2022 | 192 | 0.420 |
Why?
|
| Animals | 18 | 2025 | 34845 | 0.410 |
Why?
|
| Serum Albumin | 1 | 2013 | 116 | 0.390 |
Why?
|
| Microcirculation | 3 | 2022 | 117 | 0.390 |
Why?
|
| Lung Transplantation | 3 | 2022 | 336 | 0.390 |
Why?
|
| Wound Healing | 2 | 2021 | 475 | 0.380 |
Why?
|
| Critical Care | 3 | 2025 | 686 | 0.360 |
Why?
|
| Endothelium | 2 | 2022 | 64 | 0.360 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 551 | 0.350 |
Why?
|
| Respiration, Artificial | 2 | 2025 | 503 | 0.350 |
Why?
|
| Sepsis | 3 | 2022 | 516 | 0.320 |
Why?
|
| Mice | 13 | 2025 | 18502 | 0.320 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 3 | 2021 | 149 | 0.320 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2020 | 66 | 0.300 |
Why?
|
| Cystic Fibrosis | 2 | 2022 | 264 | 0.300 |
Why?
|
| Humans | 39 | 2025 | 132081 | 0.290 |
Why?
|
| Child | 23 | 2025 | 25758 | 0.280 |
Why?
|
| Acute-On-Chronic Liver Failure | 2 | 2021 | 78 | 0.280 |
Why?
|
| Biliary Atresia | 2 | 2023 | 206 | 0.280 |
Why?
|
| Inflammation | 5 | 2022 | 1522 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4758 | 0.270 |
Why?
|
| Endothelial Cells | 1 | 2010 | 526 | 0.270 |
Why?
|
| Male | 20 | 2025 | 64952 | 0.260 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 509 | 0.250 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2024 | 19 | 0.250 |
Why?
|
| Multiple Organ Failure | 3 | 2022 | 145 | 0.240 |
Why?
|
| Infant | 12 | 2025 | 13037 | 0.230 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2025 | 92 | 0.230 |
Why?
|
| Cytokines | 2 | 2025 | 1365 | 0.230 |
Why?
|
| Child, Preschool | 13 | 2025 | 14719 | 0.230 |
Why?
|
| Venules | 2 | 2022 | 28 | 0.230 |
Why?
|
| Leukocytosis | 1 | 2025 | 48 | 0.230 |
Why?
|
| Leukocyte Count | 1 | 2025 | 249 | 0.220 |
Why?
|
| Liver | 2 | 2022 | 1797 | 0.220 |
Why?
|
| Factor XIII Deficiency | 1 | 2024 | 4 | 0.220 |
Why?
|
| Death | 1 | 2025 | 79 | 0.210 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2024 | 11 | 0.210 |
Why?
|
| Video Games | 1 | 2025 | 98 | 0.210 |
Why?
|
| Blood Component Removal | 1 | 2023 | 35 | 0.210 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2021 | 99 | 0.200 |
Why?
|
| Macrophages | 2 | 2025 | 692 | 0.200 |
Why?
|
| Ferritins | 2 | 2021 | 109 | 0.200 |
Why?
|
| Arginine | 1 | 2025 | 343 | 0.200 |
Why?
|
| Female | 17 | 2025 | 70699 | 0.200 |
Why?
|
| Hospital Costs | 1 | 2024 | 183 | 0.190 |
Why?
|
| Craniocerebral Trauma | 1 | 2024 | 138 | 0.190 |
Why?
|
| Hemostatics | 1 | 2022 | 60 | 0.190 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 204 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1224 | 0.180 |
Why?
|
| Tissue and Organ Procurement | 1 | 2025 | 246 | 0.180 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2021 | 3 | 0.180 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 9 | 0.180 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2021 | 3 | 0.180 |
Why?
|
| Liver Cirrhosis | 4 | 2023 | 898 | 0.180 |
Why?
|
| CD18 Antigens | 1 | 2021 | 44 | 0.180 |
Why?
|
| Hyperemia | 1 | 2021 | 35 | 0.180 |
Why?
|
| Cell Degranulation | 1 | 2021 | 29 | 0.180 |
Why?
|
| Thromboembolism | 1 | 2022 | 93 | 0.170 |
Why?
|
| Retrospective Studies | 11 | 2024 | 17367 | 0.170 |
Why?
|
| Critical Illness | 6 | 2022 | 617 | 0.170 |
Why?
|
| Vasculitis | 1 | 2021 | 50 | 0.170 |
Why?
|
| Mast Cells | 1 | 2021 | 67 | 0.170 |
Why?
|
| Interferometry | 1 | 2020 | 24 | 0.170 |
Why?
|
| ADAMTS13 Protein | 1 | 2021 | 66 | 0.170 |
Why?
|
| Erythrocytes | 1 | 2021 | 201 | 0.170 |
Why?
|
| Virus Replication | 1 | 2024 | 636 | 0.170 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2025 | 466 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 152 | 0.160 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 142 | 0.160 |
Why?
|
| Centrifugation | 3 | 2024 | 24 | 0.160 |
Why?
|
| Protein Domains | 1 | 2020 | 260 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2021 | 212 | 0.150 |
Why?
|
| Tracheostomy | 1 | 2021 | 203 | 0.150 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 37 | 0.150 |
Why?
|
| Rats | 1 | 2025 | 3604 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2024 | 995 | 0.140 |
Why?
|
| Extracorporeal Circulation | 1 | 2018 | 55 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2021 | 323 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 605 | 0.140 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2018 | 28 | 0.140 |
Why?
|
| Coronary Care Units | 1 | 2017 | 33 | 0.130 |
Why?
|
| Plasma Exchange | 1 | 2018 | 88 | 0.130 |
Why?
|
| Fibrin | 3 | 2022 | 64 | 0.130 |
Why?
|
| Transportation of Patients | 1 | 2017 | 53 | 0.130 |
Why?
|
| Cornea | 1 | 2021 | 569 | 0.130 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 264 | 0.130 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 158 | 0.130 |
Why?
|
| Protein Binding | 1 | 2020 | 1734 | 0.130 |
Why?
|
| Patient Admission | 1 | 2017 | 186 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 233 | 0.120 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 270 | 0.120 |
Why?
|
| Pediatrics | 1 | 2025 | 1208 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 84 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 130 | 0.110 |
Why?
|
| Bile Acids and Salts | 2 | 2023 | 255 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2018 | 385 | 0.110 |
Why?
|
| Anemia | 1 | 2018 | 350 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8540 | 0.110 |
Why?
|
| Platelet Function Tests | 1 | 2013 | 41 | 0.100 |
Why?
|
| Cell Movement | 2 | 2021 | 890 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2015 | 794 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2012 | 109 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4687 | 0.090 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 111 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 189 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2010 | 68 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3129 | 0.090 |
Why?
|
| Coinfection | 1 | 2012 | 188 | 0.080 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 63 | 0.080 |
Why?
|
| Bile Duct Diseases | 1 | 2010 | 17 | 0.080 |
Why?
|
| Risk Factors | 5 | 2023 | 10936 | 0.080 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 198 | 0.080 |
Why?
|
| Adolescent | 7 | 2024 | 20530 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1163 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 861 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 479 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 158 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2021 | 3868 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 569 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 3086 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1718 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2022 | 140 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2012 | 700 | 0.060 |
Why?
|
| Argininosuccinate Synthase | 1 | 2025 | 25 | 0.060 |
Why?
|
| Heart | 1 | 2010 | 689 | 0.060 |
Why?
|
| RAW 264.7 Cells | 1 | 2025 | 46 | 0.060 |
Why?
|
| Length of Stay | 2 | 2024 | 1380 | 0.060 |
Why?
|
| Myocardium | 1 | 2010 | 907 | 0.060 |
Why?
|
| Argininosuccinate Lyase | 1 | 2025 | 65 | 0.060 |
Why?
|
| Factor XIII | 1 | 2024 | 7 | 0.050 |
Why?
|
| Filtration | 1 | 2024 | 22 | 0.050 |
Why?
|
| Citrulline | 1 | 2025 | 115 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 1294 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2025 | 306 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2022 | 85 | 0.050 |
Why?
|
| Organ Dysfunction Scores | 1 | 2022 | 50 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2022 | 43 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 172 | 0.050 |
Why?
|
| Organ Transplantation | 1 | 2025 | 180 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2025 | 470 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 157 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2022 | 44 | 0.050 |
Why?
|
| Incidence | 2 | 2021 | 3370 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2021 | 13015 | 0.050 |
Why?
|
| Adult | 3 | 2023 | 31558 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2021 | 57 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2025 | 503 | 0.040 |
Why?
|
| Collagen | 1 | 2022 | 303 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 341 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2024 | 407 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2021 | 101 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 136 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2021 | 191 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 278 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 469 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 539 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2021 | 237 | 0.040 |
Why?
|
| Regeneration | 1 | 2021 | 225 | 0.040 |
Why?
|
| Cold Ischemia | 1 | 2018 | 23 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2018 | 55 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 92 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 69 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2025 | 1072 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 1307 | 0.030 |
Why?
|
| Operative Time | 1 | 2018 | 190 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1571 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 6443 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2018 | 181 | 0.030 |
Why?
|
| Doxycycline | 1 | 2018 | 121 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 104 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 99 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2017 | 76 | 0.030 |
Why?
|
| Antibodies | 1 | 2018 | 366 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 373 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 507 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1966 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2018 | 559 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1185 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 337 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1126 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 389 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1440 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 1460 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3753 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2012 | 15 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 1230 | 0.020 |
Why?
|
| Medical Audit | 1 | 2012 | 101 | 0.020 |
Why?
|
| Vasoplegia | 1 | 2012 | 18 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2232 | 0.020 |
Why?
|
| Phenotype | 2 | 2012 | 4539 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3414 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 5013 | 0.020 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2010 | 3 | 0.020 |
Why?
|
| Glycogen | 1 | 2010 | 53 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2010 | 52 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6557 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 212 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 9938 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5169 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 304 | 0.020 |
Why?
|
| Fatigue | 1 | 2010 | 201 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 421 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11652 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2010 | 356 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 303 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5407 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2551 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1563 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 3727 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 4718 | 0.010 |
Why?
|